Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin α4β7 is a heterodimeric cell surface receptor that plays a critical role in immune cell trafficking, particularly in directing lymphocytes to gut-associated lymphoid tissues. It is composed of alpha-4 (CD49d; gene: ITGA4) and beta-7 (gene: ITGB7) subunits. α4β7 mediates adhesion and migration of lymphocytes by binding to specific ligands like MAdCAM-1, VCAM-1 and fibronectin, promoting homing of T and B lymphocytes to intestinal mucosa.
Adhesion and migration of lymphocytes by binding to MAdCAM-1, VCAM-1, and fibronectin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha-4 beta-7 heterodimer (α4β7).